TY - JOUR
T1 - Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
JO - Health technology assessment (Winchester, England)
PY - 2007/03/01
AU - Tappenden P
AU - Jones R
AU - Paisley S
AU - Carroll C
ED -
VL - 11
IS - 12
Y2 - 2025/07/29
ER -